{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:00:02Z","timestamp":1787320802340,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020T130057ZX"],"award-info":[{"award-number":["2020T130057ZX"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.cbi.2022.109954","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:16:39Z","timestamp":1650593799000},"page":"109954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19"],"prefix":"10.1016","volume":"361","author":[{"given":"Xiuge","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.109954_bib1","unstructured":"http:\/\/covid19.Who.Int\/."},{"key":"10.1016\/j.cbi.2022.109954_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cbi.2022.109954_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cbi.2022.109954_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cbi.2022.109954_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2022.109954_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2022.109954_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2022.109954_bib8","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","article-title":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome","volume":"127","author":"Roncon","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cbi.2022.109954_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11154-021-09630-8","article-title":"Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis","volume":"22","author":"Corona","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cbi.2022.109954_bib10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/1753-0407.13085","article-title":"Factors leading to high morbidity and mortality of covid-19 in patients with type 2 diabetes","volume":"12","author":"Rajpal","year":"2020","journal-title":"J Diabetes"},{"key":"10.1016\/j.cbi.2022.109954_bib11","doi-asserted-by":"crossref","first-page":"576093","DOI":"10.3389\/fphar.2021.576093","article-title":"Repurposing chloroquine against multiple diseases with special attention to SARS-CoV-2 and associated toxicity","volume":"12","author":"Kamat","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cbi.2022.109954_bib12","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.21037\/apm-21-400","article-title":"Comparison of the antiviral effect of arbidol and chloroquine in treating COVID-19","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.cbi.2022.109954_bib13","unstructured":"http:\/\/www.Nhc.Gov.Cn\/yzygj\/s7653p\/202002\/8334a8326dd94d329df351d7da8aefc2.Shtml."},{"key":"10.1016\/j.cbi.2022.109954_bib14","unstructured":"http:\/\/www.Nhc.Gov.Cn\/xcs\/zhengcwj\/202003\/46c9294a7dfe4cef80dc7f5912eb1989.Shtml."},{"key":"10.1016\/j.cbi.2022.109954_bib15","unstructured":"http:\/\/www.Fda.Gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and."},{"key":"10.1016\/j.cbi.2022.109954_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcpt.13267","article-title":"Chloroquine and hydroxychloroquine for COVID-19: perspectives on their failure in repurposing","volume":"46","author":"Shah","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.cbi.2022.109954_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.584940","article-title":"The rise and fall of chloroquine\/hydroxychloroquine as compassionate therapy of COVID-19","volume":"12","author":"Manivannan","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cbi.2022.109954_bib18","first-page":"185","article-title":"Department of Science Technology of Guangdong and Province Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus, pneumonia, Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia","volume":"43","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"key":"10.1016\/j.cbi.2022.109954_bib19","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited","volume":"57","author":"Gautret","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cbi.2022.109954_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cbi.2022.109954_bib21","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/s41467-021-22446-z","article-title":"Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials","volume":"12","author":"Axfors","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbi.2022.109954_bib22","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with COVID-19","volume":"383","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cbi.2022.109954_bib23","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/jama.2020.22240","article-title":"Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial","volume":"324","author":"Self","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2022.109954_bib24","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cbi.2022.109954_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cbi.2022.109954_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41586-020-2575-3","article-title":"Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2","volume":"585","author":"Hoffmann","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.109954_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106144","article-title":"Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants","volume":"56","author":"Catteau","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cbi.2022.109954_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of COVID-19 autopsies","volume":"184","author":"Nie","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.109954_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: a narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J Mol Histol"},{"key":"10.1016\/j.cbi.2022.109954_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2020.1817479","article-title":"Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose","volume":"59","author":"Doyno","year":"2021","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cbi.2022.109954_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00296-021-04868-6","article-title":"Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities","volume":"41","author":"Muller","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cbi.2022.109954_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph0547s70","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.cbi.2022.109954_bib33","series-title":"Experimental Methodology of Pharmacology","author":"Xu","year":"2002"},{"key":"10.1016\/j.cbi.2022.109954_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000355535","article-title":"Exogenous nerve growth factor promotes the repair of cardiac sympathetic heterogeneity and electrophysiological instability in diabetic rats","volume":"127","author":"Xue","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.cbi.2022.109954_bib35","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1080\/15548627.2020.1796014","article-title":"Chloroquine in fighting COVID-19: good, bad, or both?","volume":"16","author":"Tang","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2022.109954_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/15563650.2020.1748194","article-title":"Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution","volume":"59","author":"Megarbane","year":"2021","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.cbi.2022.109954_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100085","article-title":"The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: a comprehensive review","volume":"10","author":"Das","year":"2021","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.cbi.2022.109954_bib38","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/bcp.14598","article-title":"Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic","volume":"87","author":"Junqueira","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cbi.2022.109954_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.apsb.2020.04.007","article-title":"Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model","volume":"10","author":"Cui","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cbi.2022.109954_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106314","article-title":"Timing and dosage may be the key in the realisation of hydroxychloroquine plus azithromycin treatment benefit in COVID-19 elderly patients","volume":"57","author":"Lacout","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cbi.2022.109954_bib41","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of qt interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2022.109954_bib42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of qt intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","volume":"5","author":"Bessiere","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cbi.2022.109954_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/cid\/ciaa394","article-title":"Towards optimization of hydroxychloroquine dosing in intensive care unit COVID-19 patients","volume":"71","author":"Perinel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cbi.2022.109954_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58631","article-title":"Concentration-dependent mortality of chloroquine in overdose","volume":"9","author":"Watson","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.cbi.2022.109954_bib45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41401-020-00519-x","article-title":"Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.cbi.2022.109954_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2021.03.028","article-title":"Safety of treatment with chloroquine and hydroxychloroquine: a ten-year systematic review and meta-analysis","volume":"88","author":"Edington","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cbi.2022.109954_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/pubmed\/fdaa074","article-title":"Hype study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern","volume":"42","author":"Nagaraja","year":"2020","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.cbi.2022.109954_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy - implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cbi.2022.109954_bib49","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/nsr\/nwaa113","article-title":"Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19","volume":"7","author":"Huang","year":"2020","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.cbi.2022.109954_bib50","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.cbi.2022.109954_bib51","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.cbi.2022.109954_bib52","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4269\/ajtmh.20-0276","article-title":"Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19","volume":"102","author":"Falcao","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cbi.2022.109954_bib53","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/0961203318768884","article-title":"The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda","volume":"27","author":"Sunkara","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.cbi.2022.109954_bib54","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.cbi.2022.109954_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.cbi.2022.109954_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs0760137","article-title":"Attenuation of streptozotocin-induced diabetes in rats by pretreatment with chloroquine","volume":"76","author":"Asamoah","year":"1989","journal-title":"Clin Sci"},{"key":"10.1016\/j.cbi.2022.109954_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1139\/y98-146","article-title":"Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent","volume":"77","author":"Emami","year":"1999","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.cbi.2022.109954_bib58","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1185\/03007995.2014.909393","article-title":"Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone","volume":"30","author":"Pareek","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cbi.2022.109954_bib59","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/art.27703","article-title":"Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases","volume":"62","author":"Rekedal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cbi.2022.109954_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.cbi.2022.109954_bib61","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jdi.13326","article-title":"Dissecting the interaction between covid-19 and diabetes mellitus","volume":"11","author":"Chee","year":"2020","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.cbi.2022.109954_bib62","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/rheumatology\/kei282","article-title":"Chloroquine inhibits production of tnf-alpha, il-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes\/macrophages by different modes","volume":"45","author":"Jang","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.cbi.2022.109954_bib63","article-title":"Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19","author":"Yu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.cbi.2022.109954_bib64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for COVID-19 - interim who solidarity trial results","volume":"384","author":"Consortium","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cbi.2022.109954_bib65","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41419-020-2720-9","article-title":"BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?","volume":"11","author":"Sharma","year":"2020","journal-title":"Cell Death Dis"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:10:12Z","timestamp":1757859012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":65,"alternative-id":["S0009279722001594"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109954","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109954"}}